Clinical trials recruiting for EGFR Overexpression
Fewer than 3 recruiting trials found.
2
Recruiting trials
1
US states with sites
2
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 1 2Phase 2 1
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Combination of MVF-HER-2 (597-626) and MVF-HER-2 (266-296) emulsified with ISA 51 | 1 |
| YH32364 | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Indiana | 1 |
Top cities
Self-screener
Recruiting trials
- Clinical Trial of YH32364 in Patients With Locally Advanced or Metastatic EGFR Overexpressing Solid Tumors
- HER-2 B Cell Peptide Vaccine
Related conditions
Trials recruiting for EGFR Overexpression often also study these conditions. Each links to its own recruiting-trial list.
Metastatic Solid Tumor 22Metastatic Esophageal Carcinoma 5Metastatic breast cancer 131Lung cancer 2180Locally Advanced Solid Tumor 4HER2-positive breast cancer 75Breast cancer 2239
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for EGFR Overexpression trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.